DiaMedica Therapeutics Inc. Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DMAC and other ETFs, options, and stocks.About DMAC
DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD).
CEORick John Pauls
CEORick John Pauls
Employees28
Employees28
HeadquartersMinneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded2000
Founded2000
Employees28
Employees28
DMAC Key Statistics
Market cap363.37M
Market cap363.37M
Price-Earnings ratio-10.15
Price-Earnings ratio-10.15
Dividend yield—
Dividend yield—
Average volume654.80K
Average volume654.80K
High today$7.41
High today$7.41
Low today$7.01
Low today$7.01
Open price$7.11
Open price$7.11
Volume396.69K
Volume396.69K
52 Week high$7.49
52 Week high$7.49
52 Week low$3.19
52 Week low$3.19
People also own
Based on the portfolios of people who own DMAC. This list is generated using Robinhood data, and it’s not a recommendation.